14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ESTA vs AHCO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
AHCO Overall Winner
6-Pillar Tally: ESTA 2 – 4 AHCO
Matrix Metrics: ESTA 4 – 6 AHCO
As of Nov 20, 2026, AdaptHealth Corp. (AHCO) is the stronger overall head-to-head candidate over Establishment Labs Holdings Inc. (ESTA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ESTA carries a Unified Composite Score of 35.7/100 (SELL) at $69.14 (N/M Forward P/E, -6.6% operating margin), whereas AHCO carries 45.2/100 (HOLD) at $7.20 (7.8x Forward P/E, 3.8% operating margin).
Growth vs. Quality Trade-Off: AHCO earns the overall head-to-head edge with a stronger Unified Composite Score (45.2/100 HOLD vs. ESTA 35.7/100 SELL) and 0.17β · 67% Vol risk profile, whereas ESTA leads top-line expansion (+33.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Competes within the Medical Devices value chain with $989.8M market capitalization and 3.8% operating margin.
OpEx & R&D Reinvestment14.4% of Rev ($495M)
90D Engineering Disclosures0 Published
Investor FAQ ESTA vs AHCO Key Questions & Quantitative Answers
As of Nov 20, 2026, AdaptHealth Corp. (AHCO) is the stronger overall head-to-head candidate over Establishment Labs Holdings Inc. (ESTA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). ESTA carries a Unified Composite Score of 35.7/100 (SELL) at $69.14 (N/M Forward P/E, -6.6% operating margin), whereas AHCO carries 45.2/100 (HOLD) at $7.20 (7.8x Forward P/E, 3.8% operating margin). Growth vs. Quality Trade-Off: AHCO earns the overall head-to-head edge with a stronger Unified Composite Score (45.2/100 HOLD vs. ESTA 35.7/100 SELL) and 0.17β · 67% Vol risk profile, whereas ESTA leads top-line expansion (+33.9% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
ESTA leads the Growth & Scale pillar: ESTA posts +33.9% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (70.2% gross margin, -6.6% operating margin), compared with AHCO at +10.9% YoY revenue growth and +6.7% YoY earnings growth on $3.44B TTM revenue (18.2% gross margin, 3.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ESTA cumulative revenue shifted +250.0% while AHCO shifted +825.7%. In operating R&D and SG&A reinvestment, ESTA deploys 76.8% of Rev ($203M) (0 90-day corporate R&D disclosures) versus 14.4% of Rev ($495M) (0 disclosures) for AHCO.
AHCO screens cheaper on headline valuation multiples. ESTA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 8.6x EV/Revenue (-8.8% FCF margin), whereas AHCO trades at 7.8x Forward P/E, 7.8x Trailing P/E, N/M PEG, and 0.9x EV/Revenue (2.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ESTA (-240.7% ROE) versus AHCO (-28.4% ROE) capital efficiency.
In options market volatility and institutional positioning, ESTA carries 58.9% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.05x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.49β · 57% Vol realized risk). By comparison, AHCO carries 66.9% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.17β · 67% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.